mRNA |
tipifarnib |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
9e-05 |
mRNA |
tacrolimus |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0001 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0001 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
0.0001 |
mRNA |
ciclopirox |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0001 |
mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0001 |
mRNA |
PD-0325901 |
gCSI |
pan-cancer |
AAC |
-0.19 |
0.0001 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0002 |
mRNA |
Oxaliplatin |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0002 |
mRNA |
EKB-569 |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.0002 |